UNIGENE LABORATORIES INC Increase (Decrease) in Receivables
UNIGENE LABORATORIES INC reported Increase (Decrease) in Receivables of $19.81 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2013-05-14
- UNIGENE LABORATORIES INC increase (decrease) in receivables for the quarter ending 2013-03-31 was $19.81K.
- UNIGENE LABORATORIES INC increase (decrease) in receivables for the quarter ending 2012-12-31 was -$1.77M, a 313.55% decline year-over-year.
- UNIGENE LABORATORIES INC increase (decrease) in receivables for the quarter ending 2012-09-30 was $176.95K, a 82.58% decline year-over-year.
- UNIGENE LABORATORIES INC increase (decrease) in receivables for the quarter ending 2012-06-30 was $832.29K.
- UNIGENE LABORATORIES INC increase (decrease) in receivables for fiscal 2012 was -$2.79M, a 348.11% decline from fiscal 2011.
- UNIGENE LABORATORIES INC increase (decrease) in receivables for fiscal 2011 was $1.12M.
- UNIGENE LABORATORIES INC increase (decrease) in receivables for fiscal 2010 was -$481.74K.
- UNIGENE LABORATORIES INC increase (decrease) in receivables for fiscal 2009 was -$2.41M.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 6 month as first filed | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 9 month as first filed | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|---|---|
| 2013-03-31 | $19.81K 10-Q · filed 2013-05-14 | -$1.75M derived: sum of 2 quarters · filed 2013-05-14 | -$1.57M derived: sum of 3 quarters · filed 2013-05-14 | -$739.79K derived: sum of 4 quarters · filed 2013-05-14 | ||
| 2012-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$1.59M derived: sum of 2 quarters · filed 2013-03-15 | -$759.60K derived: sum of 3 quarters · filed 2013-03-15 | -$2.79M 10-K · filed 2013-03-15 | ||
| 2012-09-30 | $176.95K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-31 | $1.01M derived: sum of 2 quarters · filed 2013-01-31 | -$1.02M 10-Q · filed 2013-01-31 | -$188.81K derived: sum of 4 quarters · filed 2013-05-14 | ||
| 2012-06-30 | $832.29K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-01-31 | -$1.19M 10-Q/A · filed 2013-01-31 | -$365.76K derived: sum of 3 quarters · filed 2013-05-14 | $650.07K derived: sum of 4 quarters · filed 2013-05-14 | ||
| 2012-03-31 | -$2.03M 10-Q · filed 2013-05-14 | -$1.20M derived: sum of 2 quarters · filed 2013-05-14 | -$182.23K derived: sum of 3 quarters · filed 2013-05-14 | -$789.58K derived: sum of 4 quarters · filed 2013-05-14 | ||
| 2011-12-31 | $828.32K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $1.84M derived: sum of 2 quarters · filed 2013-03-15 | $1.24M derived: sum of 3 quarters · filed 2013-03-15 | $1.12M 10-K · filed 2013-03-15 | ||
| 2011-09-30 | $1.02M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-31 | $408.47K derived: sum of 2 quarters · filed 2013-01-31 | $294.56K 10-Q · filed 2013-01-31 | -$294.56K 10-Q · filed 2011-11-09 | -$191.13K derived: sum of 4 quarters · filed 2013-03-15 | |
| 2011-06-30 | -$607.35K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-01-31 | -$721.27K 10-Q/A · filed 2013-01-31 | $721.27K 10-Q · filed 2011-08-09 | -$1.21M derived: sum of 3 quarters · filed 2013-03-15 | -$1.85M derived: sum of 4 quarters · filed 2013-03-15 | |
| 2011-03-31 | -$113.92K 10-Q/A · filed 2013-01-31 | -$599.60K derived: sum of 2 quarters · filed 2013-03-15 | -$1.24M derived: sum of 3 quarters · filed 2013-03-15 | |||
| 2010-12-31 | -$485.69K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$1.13M derived: sum of 2 quarters · filed 2013-03-15 | -$481.74K 10-K · filed 2013-03-15 | |||
| 2010-09-30 | -$644.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $3.94K 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $648.91K 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | -$2.41M 10-K/A · filed 2013-01-31 |